Yelak Biru Announces Departure as President and CEO of the International Myeloma Foundation

Yelak Biru has announced that he will be stepping down as President and CEO of the International Myeloma Foundation (IMF). A multiple myeloma survivor and advocate, Biru shared the news in a statement reflecting on his journey and tenure at the IMF.

In a post on X, he wrote:

“I have determined that the time is right to pass the torch and allow new leadership to guide the International Myeloma Foundation (IMF) into its next chapter.”

Photo credit to Yelak Biru/X

Biru described his decision as one made after “thoughtful reflection,” expressing confidence in the foundation’s future. Looking ahead, he acknowledged the uncertainties of his next steps but embraced them with optimism:

“Now, I stand at a personal crossroads. I don’t know exactly what tomorrow will bring, but I am embracing the uncertainty with HOPE. The unknown has shaped my life and led me through an amazing journey. I can’t wait to see what adventures await.”

He also expressed gratitude to the IMF and its community, saying:

“I do so with immense gratitude—for the journey, the people, and the progress we’ve made together. I have full confidence in the IMF’s continued success.”

Photo credit to Yelak Biru/X

About Yelak Biru

Yelak Biru’s story is one of survival, purpose, and dedication. Born in Ethiopia, he was diagnosed with multiple myeloma just before his 26th birthday while in graduate school. At the time, doctors gave him only two to three years to live. But through a combination of cutting-edge treatments, faith, and the support of those around him—what he calls his “air, land, and sea” strategy—he has lived with the disease for nearly 30 years.

In the video titled “My 28-Year Journey as a Multiple Myeloma Cancer Patient,” Yelak Biru shares his experience living with multiple myeloma.

Rather than letting cancer define him, Yelak turned his experience into a mission. He became a globally recognized research advocate, working with leading organizations like the National Cancer Institute (NCI), ECOG-ACRIN, and Cancer Research UK’s Cancer Grand Challenges. His focus has always been on ensuring better resources, support, and access to treatment for patients worldwide.

With a master’s degree in computer science, Yelak built a successful career in data analytics, holding leadership positions at PepsiCo for 20 years, where he worked in roles including Global Director of Advanced Analytics and Business Intelligence Architecture. He later joined Walmart Global Tech as Senior Director of Data Analytics, Global People Analytics, leading innovative data-driven strategies from 2017 to 2021.

Despite his success in the corporate world, Yelak’s passion for patient advocacy ultimately led him to the International Myeloma Foundation (IMF), where he became President and CEO in 2021. During his tenure, he helped redefine the organization’s mission, envisioning “a world where every myeloma patient can live life to the fullest, unburdened by the disease.” He broadened the IMF’s global impact by increasing research funding, forming strategic collaborations, and launching innovative patient support initiatives.

Under his leadership, the IMF introduced Myelo, an AI-powered platform offering personalized, real-time support for myeloma patients and caregivers. He spearheaded the creation of the IMF’s Scientific Advisory Board, driving strategic research priorities, and expanded scientific research efforts into Latin America and Asia. Additionally, he helped extend the Global Myeloma Action Network (GMAN) and played a key role in leveraging the FDA’s ODAC committee’s positive vote on Minimal Residual Disease (MRD) as an early clinical trial indicator, leading to the launch of the i2TEAMM initiative in Europe.

Photo credit to Yelak Biru/X

Beyond his professional achievements, Yelak has been a strong advocate for digital equity and global access to cancer research. His leadership positioned the IMF at the forefront of innovation, collaboration, and patient-centered research in myeloma.

At the heart of Yelak’s journey is an unwavering commitment to making a difference. He is a survivor who understands the human impact of cancer firsthand. His story is one of resilience, hope, and service—driven by a determination to ensure that every patient, no matter where they are, has access to the care, knowledge, and support they need to live a full and meaningful life.

About the International Myeloma Foundation

The International Myeloma Foundation (IMF), founded in 1990, is the largest global organization dedicated to multiple myeloma. It focuses on four key areas: research, education, support, and advocacy. The IMF provides resources for patients, caregivers, and healthcare professionals, including educational seminars, a patient hotline, and multilingual publications. Its mission is to improve the quality of life for myeloma patients while working toward a cure. The IMF envisions a world where every myeloma patient can live life to the fullest, free from the disease’s burden.

Stay tuned to OncoDaily for further updates.